Pulmonary Health in Children With Down Syndrome

NCT ID: NCT04398862

Last Updated: 2024-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-21

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the study is to learn more about tests that can assess lung health in children with Down syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Down Syndrome Dysphagia, Oropharyngeal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with Down syndrome and aspiration

Outcomes will be compared between two groups although no intervention is submitted, this is an observational study.

No interventions assigned to this group

Children with Down syndrome without aspiration

Outcomes will be compared between two groups although no intervention is submitted, this is an observational study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged 3 to 18 years, inclusive, at time of consent
* Diagnosis of Down syndrome/trisomy 21 or mosaicism
* Able to walk
* Had a swallow study (video fluoroscopic swallow study or fiberoptic endoscopic evaluation of swallowing) performed within 5 years of consent date

Exclusion Criteria

* Pregnant or lactating
* Nonambulatory
* Have a tracheostomy or other known severe glottic or subglottic obstruction that would significantly affect the results of testing
* Have a significant acute respiratory illness, defined as treatment with steroids, antibiotics, or an increase in supplemental oxygen
* have a medical illness that would a)increase the risk the participate would incur by participating in the study, b) interfere with the outcomes of the study, or c) interfere with the performance of study participants
* Have a severe behavioral problem that would interfere with the performance of study procedures
Minimum Eligible Age

3 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emily DeBoer, MD, MSCS

Role: PRINCIPAL_INVESTIGATOR

University of Colorado, Denver

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital Colorado

Aurora, Colorado, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Allison Keck

Role: CONTACT

720-777-6860

Rawan Jarrar

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emily DeBoer, MD

Role: primary

720-777-4953

Kate Smith, PhD

Role: backup

720-777-6181

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21HL151261-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

19-2092

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Severe Lung Disease in Childhood
NCT06455800 RECRUITING
Lung Health Study (LHS) I and III
NCT00000568 COMPLETED PHASE3